Assessment-based prediction is the basis to good candidate hiring

Hiring is among the most important activities for an organization, because it is the process by which the organization takes in its most important resource –people. At the time of hiring, as well as while considering promoting, HR and the other important decision makers need to make up their mind by asking critical questions with which to make predictions about a potential hire. These questions could relate to how well the resource can perform in the assigned role, for how long the resource could stay in the organization, and making an assessment about the person’s ability to handle more responsibilities.

Not all HR and other hiring managers could be right all the time in predicting the outcomes of their actions about a candidate; yet, a good understanding of principles of assessing the candidate, combined with proper preparation and inculcation of a little disciple will go a long way in helping them become more accurate in their predictions. When the hiring managers are not too way off their mark in predicting the attributes of a useful hire, they are more likely to get a better candidate and avoid much of the unpleasantness that a bad hire can cause.

Learn the art of predicting the usefulness and relevance of a candidate

It is to equip participants with the tools needed to design a process for selecting and promoting for any position across any industry that a two-day, in person seminar is being organized by GlobalCompliancePanel, a leading provider of professional trainings for the areas of regulatory compliance. This seminar’s Director is Harry Brull, who is President, Laurdan Associates, Inc. and Co-Founder of BCG Consulting Group.

To get an understanding of how to get the right insight into a selection process that is relatively error-free and effective, just log on to

http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900715.

Insights into getting the hiring and promoting process right

At this seminar, Harry will explore the use of standardized instruments in designing and using simulations for maximizing return on references. This is in addition to the most often-used selection tool, the pre-employment interview.

He will also discuss other important areas of the hiring process, like defensibility and avoiding complaints from unsuccessful applicants, ways of judging a candidate’s interpersonal skills, other capabilities and motivators, and other factors which determine whether there is a good fit between the individual, the position, and the organization.

In addition, Harry will also look at adding other selection tools such as testing and simulations (job samples) to the selection tool mix, which can greatly improve prediction accuracy and provide an alternative view of candidate skills, and techniques which improve the usefulness of reference information, including eliciting vital information from sometimes reluctant sources. 

Verification vs validation is a key understanding for regulatory professionals

For regulatory professionals, aspects of verification and validation, such as how to get verification and validation right, and an understanding of the ways in which verification and validation diverge from each other and converge, make up very important learning. The key point is that verification and validation should be risk based and be built keeping in mind the extant regulatory expectations.

Building a verification and validation process that sufficiently uses targeted and documented risk based verification and validation test case elements or scripts is the foundation to this. All these have to be reviewed against ISO 14971 and ICH Q 9 hazard analysis and product risk management.

Getting their V & V right involves gaining and exercising proper knowledge of these areas on the part of professionals working in regulatory environments. This learning is what a two-day seminar by GlobalCompliancePanel, a very well-known provider of professional trainings for all the areas of regulatory compliance, will impart.

V & V against the regulatory process

The Director of this seminar, John E Lincoln, a senior Consultant for Medical device and Regulatory Affairs, will explain the rationale behind verification and validation and clear all the ambiguities relating to this activity.

He will help participants to understand the following:

o   Evaluating different field-tested, U.S. FDA-reviewed V&V protocols

o   Ways by which to employ equipment/process Requirements Specs/DQs, IQs, OQs, and PQs, or their equivalents per ASTM E2500. John E Lincoln will help participants how to do all these against a background of limited company resources

o   Reviewing a matrix that simplifies “as-product”, “in-product”, process and equipment and related matters

o   Software VT&V to ensure that key FDA requirements are not overlooked

To enroll for this course, just log on to

http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900645SEMINAR?verification-vs-validation-qms-Las-Vegas.

The Director will also offer hands-on understanding of Quality Management Systems and 21 CFR Part 11. This seminar will help participants:

o   Understand Verification and Validation, differences and how they work together;

o   Discuss recent regulatory expectations;

o   Know how to document a "risk-based" rationale, and use it in a resource-constrained environment;

o   Determine key "milestones" and "tasks" in a project;

o   Locate and document key subject "inputs";

o   Compile "generic" Master and Individual Validation Plans;

o   Learn the key element of a Product V&V File/Protocol;

o   Understand how to develop Process and/or Production/Test Equipment V&V Files/Protocols;

o   Get a grasp of basic Test Case construction;

o   Understand sample sizes and their justification;

o   Learn the key elements of Software V&V expected by the FDA and how to document;

o   Deal with hardware and software vendors, sales and marketing

o   Consider a field-tested software V&V documentation "model";

o   See how to compile QMS Electronic Records and Electronic Signatures V&Vs to satisfy 21 CFR Part 11.

Get your HIPAA compliance right in six simple steps

The most important element that Covered Entities and Business Associates must keep in mind while carrying out HIPAA audits is best summarized in the words of Jocelyn Samuels, the top Federal official in charge of HIPAA enforcement. To quote her own words, Covered Entities and Business Associates must ensure compliance through “... a comprehensive and thorough approach to assessing and addressing the risks to all of the Protected Health Information (PHI) they maintain”.

Although Risk Analysis is mandatory; HIPAA audits of 2012 showed that as many as four fifths of health care providers failed to comply with this mandatory requirement. Covered Entities and Business Associates are under severe pressure to do a HIPAA Risk Analysis of all the PHI’s they maintain. Most of this, they are expected to do on their own. This explains perhaps just why 80% of health care providers failed to do the Risk Analysis, a fact discovered by the HHS. In fact, the incidence of HIPAA violations has been increasing so steeply that 2015 was sardonically referred to in HIPAA circles as the “Year of the Breach”. This fact leads to the next important point: higher and greater number of government enforcement and private lawsuits.

Learn the ways of getting HIPAA compliance right in just six simple steps

The above facts make it absolutely imperative for Covered Entities and Business Associates to get every aspect of the HIPAA compliance right, in the manner suggested by Jocelyn Samuels. This is precisely what GlobalCompliancePanel, a highly renowned provider of professional trainings for all areas of regulatory compliance, will be imparting at a two-day, in person seminar. To enroll for his event, just visit

http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900616SEMINAR?master-HIPAA-compliance-six-steps-San-Diego.

The Director of this highly meaningful and valuable seminar is the well-known expert on HIPAA compliance, Paul Hales. Paul’s credentials get augmented by the fact that he has, with a team of expert advisors and practical field testers, created a method of making all HIPAA regulations accessible to the everyday person. Paul’s method explains all the aspects of HIPAA in uncomplicated and simple language and carries the exact citations to each regulation. This method is directed at organizations’ legal counsel who may not be well versed or experienced in HIPAA, and will be a major part of this seminar. 

Major benefits by learning from the expert

Organizations that are required to carry out HIPAA audits will gain enormously from this seminar. It will help them to save money, time, and research. Paul will discuss how Business Associates and Covered Entities can grow their practice and be compliant. His method will serve as the very foundation on which organization can implement their HIPAA Compliance Program. Most importantly, he will teach how they can grow what is most valuable to their business: Their patients. Paul’s HIPAA compliance method, which consists of six easy steps, will create a level of quality to the advice that the legal counsel provides.

He will take participants of this seminar through a Risk Analysis for their organization and will also delve into the Privacy, Breach, and Security Rules as applicable to their particular organization. 

Application of concepts and theories of clinical research

Protection of human subjects and everything relating to it is of paramount importance for those involved in or wanting to be involved in research dealing with human subjects or an individual's private identifiable information. For these individuals, professionals and companies, it is extremely important to understand that there are federal regulations that must be followed.

There are also state statutes, institutional policies, federal guidance documents, and ethical codes that guide the conduct of the research. This is done to ensure that the research not only meets the regulatory requirements but also that it is conducted in an ethical manner, coming with adequate protections for the individuals who elect to enroll in the research or allow their information to be used for research.

Guidelines lack clarity

However, the challenge that this position presents is that the guidelines –which also provide interpretation of the regulations –are not always as clear as they might appear upon first reading them.

A two-day seminar from GlobalCompliancePanel, a leading provider of professional trainings for all the areas of regulatory compliance, will impart understanding on all these grey areas of human subjects. It will clarify on these regulations.

The Director of this seminar is the highly regarded expert on the subject, Sarah Fowler-Dixon, Education Specialist and instructor with Washington University School of Medicine. Sarah has developed a comprehensive education program for human subject research which has served as a model for other institutions. To enroll for this highly educative session, just log on to

http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900669SEMINAR?human-subjects-research-seminar-San-Diego-CA.

Ways of applying concepts and theories

This two-day seminar will provide the foundation for the application, concepts and theories of clinical research.

The speaker will not only provide a refresher of the regulations; she will also provide attendees with the opportunity to discuss and learn how these regulations, ethical codes and guidance documents get applied in different situations. This information can then be used to help attendees in their day-to-day decision making when confronted with situations or questions regarding how to handle issues that do arise (e.g. a participant not showing for a scheduled appointment, an event that is unexpected occurs, someone who does not speak wishes to enroll in the study, a participant signing an outdated consent document, etc.) when conducting human subjects.

Outcomes of the seminar

The learning acquired over these two days will help attendees learn about the historical evolution of research, and current regulations and guidelines including the Common Rule, FDA regulations and HIPAA. This session will discuss site and study staff responsibilities in the conduct and reporting of research, types of studies and the regulatory requirements that apply to different study designs. It will also discuss a variety of research including genetic, drug, device, and studies that use off-site or community partners. Current examples will be used and the audience will be invited to share their experiences and information.

Handle internal investigations thoroughly, else employees could approach law agencies

Employees have a right to approach external sources such as the Equal Employment Opportunity Commission (EEOC), the National Labor Relations Board (NLRB), Wage and Hour, private attorneys, and juries against the employers, when feel that their legitimate complaints are not being heard by their employers.

But first, a clear definition has to be made of what constitutes legitimate complaints and a distinction has to be made between legitimate and unsubstantiated complaints. This is because employers are legally empowered and obliged to carry out certain kinds of investigation, namely the kind done on what the law considers as a legitimate employee complaint, and not others. It is thus important for employers to have a thorough understanding of what type of complaint is considered by the law as legitimate and what is not.

Follow the procedures to be safe at investigations

This distinction determines whether the employee will go to any of the external agencies mentioned above to complain against the employer or not. Further, quick and sound action that is legally compliant will also help juries or other agencies decide whether or not the employers took quick and appropriate action to address legitimate employee complaints. Following the right procedures will help to protect the organization against such complaints, if the juridical sources find that the employer took the right action on time to redress the employee’s legitimate complaint.

HR has to be quick and has to think on its feet if it is to avoid giving the employee the opportunity to approach an external agency, the fallout of which can be potentially damaging. In order to help HR professionals understand the way by which to carry out a legally tenable and fair investigation of the complaints; GlobalCompliancePanel, a leading global provider of professional trainings in all areas of regulatory compliance, will organize a two-day seminar.

To enroll for this seminar, please log on to

http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900677SEMINAR?conducting-internal-investigations-San-Diego-CA.

Susan Fahey Desmond, a principal with Jackson Lewis PC and noted author and speaker, will be the Director of this seminar.  Susan will offer a thorough understanding of how to classify a complaint by the employee as a legitimate one. Lack of this knowledge on the part of the organization’s HR will result in having to battle it out in court. 

Maximizing profits and patient outcomes during times of dwindling reimbursements

Shrinking professional services reimbursements from all insurance companies is a fact that all practices are facing. With patient footfalls falling and operating costs skyrocketing; there is a need for everyone to look at ways by which to generate additional revenue opportunities with their existing patient base and at the same time, maximize patient clinical outcomes.

There exist methods by which all these goals can be achieved. The ways of doing this will be the subject of a two-day seminar that is being organized by GlobalCompliancePanel, a well-known provider of professional trainings for all the areas of regulatory compliance. Gregory J. Simms, President and CEO of DME Advanta, LLC., will be the Director at this seminar. Just log on to

http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900625SEMINAR to enroll for this  seminar.

Look for the DME option

Simms will demonstrate very practical and simple ways of maximizing revenue and profit to participants from their practice and ways of offering better service outcomes for their patients from their existing patient base. A very important learning he will offer is the ways to set up a Durable Medical Equipment (DME) Revenue Program, which will unlock the keys to financial success in the range of $5,000-$25,000 profit per doctor per month, all with a limited number of patients, and while at the same time staying legally compliant.

Practitioners for years have been referring the business to O&P shops, manufacturers or 3^rd parties because they have all along believed that it is illegal and not profitable. If done following proper guidelines and regulations with appropriate protocols and processes, these can be developed into a full-fledged, profitable program that greatly enhances the value they provide to their patients, as well as their own practices.

A comprehensive set of materials

Apart from explaining the ways of doing this, Director Simms will provide participants with the following critical information and materials at this seminar:

o   How to develop Profits $5,000-$20,000+ per month, per doctor though DME (with but a few patients a week or day)

o   How to become immediate positive cash-flow

o   How to provide a “Convenient One-Stop Medical Shopping” for patients

o   How to maximize “Clinical Outcomes”

o   How to acquire a Medicare DME PTAN license

o   How to become fully accredited and treat numerous practices patients

o   Surgical & non-surgical protocols

o   Criteria to prove medical necessity with formulated SOAP Notes and diagnosis codes

o   Legal Compliance program that addresses all federal & state guidelines

o   The keys to dealing with private insurances, Workers Compensation cases and Personal Injury cases

o   Audits and how to proactively prepare so you never need to worry

He will cover the following areas at this seminar:

o   Return on Investments (Strategic & Financial)

o   Medicare & Accreditation

o   Policies & Processes

o   Executing a Legal Compliance Program

Medical products need to be validated for Radiation Sterilization

“Do it right the first time” should be the mantra for medical device manufacturers that plan to make radiation products. Choosing the most functional and radiation resistant materials for their medical device will help them avoid the trouble of going through the post launch cycle of product revisions.

To get this right, one simple line of thinking is crucial for medical device manufacturers to inculcate: To “think like a molecule”. This is the basis on which to plan and design around radiation induced changes in the qualities such as color, odor and brittleness that go into the materials.

Learning the right method

Professionals in the medical devices industry, who work on these aspects will benefit immensely from a two-day seminar on the topic, “Validating Radiation Sterilization for Medical Products”, which is being organized by GlobalCompliancePanel, a highly popular provider of professional trainings for all areas of regulatory compliance.

The Director of this seminar, Karl J. Hemmerich, President of Ageless Processing Technologies, who brings over 35 years of experience in medical device product design, development, manufacturing, and sterilization, will offer a range of learning on this topic.

Identifying the best suited materials

Apart from helping participants identifying the materials that perform best upon radiation, keeping color and odor out of their irradiated products and enhancing product and packaging designs to take advantage of radiation; he will also offer understanding to them on how to avoid the materials that are certain to fail.

This seminar, for which medical device professionals can enroll by visiting http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900685SEMINAR?validating-radiation-Washington-DC, has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.

Understanding optimum sterilization modality

Participants will also learn the basis for choosing the optimum sterilization modality based on materials, product design, bioburden, and logistics and understand which modality (Gamma, E-beam, or X-ray) will perform best for their product.

Karl will cover the areas relating to validation of radiation sterilization for medical products, such as Materials Guidances - AAMI TIR # 17, ASTM, sterilization validation and bioburden, Shelf Life Test Methods - Accelerated Aging design, Test Design, Product Design, the influences of product assembly (molding, automation, etc.), material selection and post irradiation degradation, Regulatory Guidances - AAMI/ISO 11137, TIR #17, packaging design and materials, and biological polymers - tissue, serum at this two-day in person seminar.

The following areas will be covered at this seminar:

o   Polymers Chemistry - choosing the best polymer candidate

o   Gamma, E-beam, X-ray sterilization

o   Accelerated Aging

o   Product Qualification

o   Sterilization Validation - Establishing the Minimum Sterilization dose (VDmax)

o   Sterilization Modality Selection Criteria

o   Biocompatibility

o   Preventing Plastic Part Failure Post Irradiation

Ensuring compliance with healthcare laws is of utmost importance for healthcare providers

Compliance with the many laws, as well as implementation of the necessary compliance initiatives are the means by which healthcare providers and entities or organizations involved in any type of healthcare transaction, especially those who bill or are involved with services payable by a CMS program, play a part in the protection of the integrity of  the CMS programs.

Developing and maintaining the necessary compliance programs that place a special emphasis on auditing and monitoring, appropriate training, receiving and responding to complaints and conducting investigations is necessary for providers, entities and organizations that bill Medicare, Medicaid or other government payor programs. Those whose compliance program fails to incorporate the necessary control processes risk inviting potential audits that could lead to civil, monetary and criminal penalties.

Understanding risks is necessary for healthcare practices

The ways by which to understand potential risks relating to their practice or organization and responding and mitigating deficiencies are all-important for healthcare organizations if they have to sustain their success and viability. This is also necessary if the organization has to avoid or neutralize the impact of negative findings by an external audit or investigative agency.

Moreover, with the many impactful changes taking place in the healthcare delivery; healthcare provider reimbursement could be affected. Quality of care and reduced costs will bring about changes into provider reimbursement for services. Healthcare providers have to understand how these changes are going to affect them.

Learning ways of implementing compliant programs

A two-day in person seminar by GlobalCompliancePanel, a highly reputable provider of professional trainings for all areas of regulatory compliance, will offer understanding on all these areas of healthcare compliance. This course, at which Gail Madison-Brown, a Registered Nurse and attorney who has spent over 25 years in the healthcare industry, and is Chief Clinical Trials Officer at UTHSCSA will be the Director,  will focus on ways by which healthcare organizations can devise means by which to stay compliant with the regulatory guidelines and laws.

To enroll for this seminar and to get a thorough understanding of how to implement practices that are compliant with regulatory requirements, just visit 

http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900544SEMINAR?ensure-healthcare-compliance-Seattle-WA.

Ways of building a robust and pragmatic compliance program

Attending this seminar will help participants understand how to build a solid and practical compliance program. Gail will introduce the basic healthcare compliance infrastructure necessary to establish a comprehensive and proactive compliance program. She will then discuss current government auditing agencies and audits that are underway, as well as government agencies responsible for protecting the Medicare Trust Fund from fraud, waste and abuse.

She will teach participants the ways of identifying risks in their organizations, no matter what their size, by conducting a risk assessment and developing a work plan based upon risk and will help with the mitigation efforts. Apart from OCR audits and how to conduct their own self-assessment in preparation for an audit, as well as ways of addressing any identified deficiencies; participants will also learn how to conduct auditing and monitoring activities and what to do with findings. Ways of putting in place a complaint management system and conducting an investigation will also be discussed. The Director will also offer user friendly templates and tools, as well as numerous case scenarios to the participants, which they can use to enhance current compliance programs.

Cleaning validation should have a policy designed to meet harsh regulatory requirements and principles

Compliance with the required cleaning validation regulatory compliance guidelines set out by the regulatory authorities such as the FDA, WHO, PIC/S and EU is essential for those who work in facilities which involve cleaning.

The reason for which adherence to these regulatory guidelines is necessary is that these cleaning procedures need to establish and demonstrate verifiable standards of hygiene and safety. Quite naturally, cleaning validation regulations are built on highly rigorous, exhaustive and challenging principles.

Many approaches and requirements

Sound scientific principles and practices should be the basis for regulatory guidelines for cleaning validation. Cleaning validation, being risk based and reasonable, should consist of informed decision-making and thorough activity planning.

To comply with cleaning validation regulatory guidelines and scientific principles; very precise concepts such as how to determine the residues to be targeted, ways by which to select the right analytical and sampling methods, how to determine the appropriate limits in various pharmaceutical and biotechnology processes and knowing by what means to establish scientific rationales that are acceptable to regulatory inspectors, need to go into cleaning.

Lots of processes need to go into cleaning validation 

These concepts should ideally lead to the development of a general policy, i.e. a “Cleaning Validation Master Plan”, into which the appropriate documentation for each study needs to be performed. Awareness of the requirements for maintenance of the validated status is necessary for those in charge of the cleaning validation program. They have to also keep the regulatory requirements and the latest industry practices in mind.

Clarity on all these topics is the intent of a detailed, two-day learning session on the topic, “Regulatory Requirements and Principles for Cleaning Validation”, which is being organized by GlobalCompliancePanel, a well-known provider of regulatory compliance trainings. To participate in this seminar, simply log on to 

http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900635SEMINAR?regulatory-requirements-Washington-DC. 

The Director of this learning session, Joy McElroy, Principal Consultant at Maynard Consulting Company, will clear all the doubts regarding cleaning validation and all its elements. Joy has gained extensive knowledge of Quality Assurance, Process and Cleaning Validation, and Equipment Qualification during the over 20 years of total experience she has had in the pharmaceutical and biotech industries, 12 of which have been as a consultant.

This course has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.

Implementing the 510 (K) correctly in compliance with the latest proposed FDA changes

A 510(K) is a premarket submission made to FDA to demonstrate that a device to be marketed is at least as safe and effective, meaning that which is substantially equivalent, to a legally marketed device that is not subject to premarket approval (PMA).

There are three types of Premarket Notification 510(K)’s that may be submitted to FDA: Traditional, Special, and Abbreviated. Product modifications that could significantly affect safety and effectiveness are subject to 510(K) submission requirements under 21 CFR 807 as well as design control requirements under the Quality System (QS) regulation. Under the QS regulation, all Class II and III devices and certain Class I devices are required to be designed in conformance with 21 CFR 820.30 Design Controls. The FDA provides guidance on these.

Needed: A thorough understanding of these aspects and the FDA’s latest proposed changes

In accordance with the concern evinced by many industry groups and associations, the FDA introduced as many as 60 proposals in August 2010, into the manner in which the 510 (K) process could be expedited. This was done with the intention of accelerating the speed at which newly approved medical devices could be made available to patients across the country. However, with the number of proposals being too many and their scope being too wide; the medical industry suggested that the FDA select for implementation only those proposals that enjoyed the broad consensus of the stakeholders, such as increased reviewer training, development of specific and relevant guidance documents, and enhancements or improvements to the de novo review pathway, among other suggestions.

An upcoming seminar by GlobalCompliancePanel, a leading provider of professional trainings for the regulatory compliance industries, will clarify on these areas taken up for immediate change by the FDA and place them in the right context. It will address key resources when making critical decisions. This seminar will offer important insights into the core areas of premarket notifications, as well as the Design Control requirements under QS regulations and Design Controls.

To enroll for this seminar, just log on to

http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900525SEMINAR?bullet-proof-510(k)-Seattle-WA

The Director at this seminar is David R. Dills, a senior Regulatory Affairs & Compliance Consultant. David provides regulatory, compliance and quality consultative services for medical device and pharmaceutical/combination manufacturers, and also has an accomplished record with more than 24 years of experience with Class I/II/III medical devices, In Vitro diagnostics, and pharmaceuticals in the areas of Regulatory Affairs, Compliance and Quality Systems.

An understanding of the core elements of the PMA

At this seminar, David will help participants understand how medical device manufacturers can locate a "predicate" device and go through the content and format of the 510(K), and offer an understanding of the De Novo process and the expectations for possibly marketing a low risk device, and the potential impact of FDA's proposed changes to the 510(K) process and why manufacturers need to pay attention to these.

He will also offer understanding of all the crucial aspects of the PMA, such as the differences between the Traditional, Special and Abbreviated submissions, an understanding of the Substantial Equivalence and how it is applied, who is required to submit the application to FDA, where to submit the 510(K) and what to expect with the review and approval process, when a device company requires this process and when it does not, the applicable exemptions to the submission process and special considerations, and so on. 

Applied Statistics for product and process evaluation in design and manufacturing

Evaluating product and processes is an imperative for almost all design and/or manufacturing companies. These are the reasons for which this evaluation needs to be made:

o   Managing risks

o   Validation of processes

o   Establishing product/process specifications to QC to such specifications

o   Monitoring compliance to such specifications

Lack of proper and thorough grasp of and correct implementation of statistical methods leads a company to having to face significant increases in its complaint rates, scrap rates, and time-to-market. As a result, such companies churn out poor quality in their products, leading to lowered customer satisfaction levels, severely impacting their bottom line.

A learning session to help understand statistical methods

In order to help professionals in process and manufacturing meet challenges associated with statistical methods with greater confidence, GlobalCompliancePanel, a highly reputable provider of professional trainings for the regulatory compliance areas, is organizing a highly educative two-day seminar on the topic, “Applied Statistics, with Emphasis on Verification, Validation, and Risk Management, in R&D, Manufacturing, and QA/QC”.

John N. Zorich, Statistical Consultant & Trainer, Ohlone College & SV Polytechnic, will be the Director at this seminar, which has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.

To enroll for this seminar, participants can log on to

http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900535SEMINAR?applied-statistics-QA-QC-Seattle-Washington.

Hands on approach to statistical methods toolbox

The aim of this seminar is to offer a hands-on approach by which the participants could comprehend the ways to interpret and use a standard tool-box of statistical methods that consist of confidence intervals, t-tests, Normal K-tables, Normality tests, confidence/reliability calculations, AQL sampling plans, measurement equipment analysis, and Statistical Process Control.

The Director will equip the seminar delegates with clarity on how to accurately employ and administer statistical methods, which can be used as a launchpad for introducing new products. 

This two-day session will help participants understand the proper way of avoiding issues relating to these aspects of statistical methods. John will explain how to apply statistics to manage risk in R&D, QA/QC, and Manufacturing by giving real life examples derived mainly from the medical device design/manufacturing industry.